Leonardi CL - Search Results

1

Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.

Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL; EFALIZUMAB STUDY GROUP. Gottlieb AB, et al. Among authors: leonardi cl. J Drugs Dermatol. 2004 Nov-Dec;3(6):614-24. J Drugs Dermatol. 2004. PMID: 15624744 Clinical Trial.

2

Efalizumab: an overview.

Leonardi CL. Leonardi CL. J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S98-104. doi: 10.1016/s0190-9622(03)01141-1. J Am Acad Dermatol. 2003. PMID: 12894132 Review.

3

Etanercept as monotherapy in patients with psoriasis.

Leonardi CL, Powers JL, Matheson RT, Goffe BS, Zitnik R, Wang A, Gottlieb AB; Etanercept Psoriasis Study Group. Leonardi CL, et al. N Engl J Med. 2003 Nov 20;349(21):2014-22. doi: 10.1056/NEJMoa030409. N Engl J Med. 2003. PMID: 14627786 Free article. Clinical Trial.

4

Efalizumab in the treatment of psoriasis.

Leonardi CL. Leonardi CL. Dermatol Ther. 2004;17(5):393-400. doi: 10.1111/j.1396-0296.2004.04042.x. Dermatol Ther. 2004. PMID: 15379774 Review.

5

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB; Efalizumab Study Group. Leonardi CL, et al. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):425-33. doi: 10.1016/j.jaad.2004.09.029. J Am Acad Dermatol. 2005. PMID: 15761420 Clinical Trial.

6

The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.

Gordon KB, Bonish BK, Patel T, Leonardi CL, Nickoloff BJ. Gordon KB, et al. Among authors: leonardi cl. Br J Dermatol. 2005 Nov;153(5):945-53. doi: 10.1111/j.1365-2133.2005.06816.x. Br J Dermatol. 2005. PMID: 16225604 Clinical Trial.

7

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.

Gordon KB, Gottlieb AB, Leonardi CL, Elewski BE, Wang A, Jahreis A, Zitnik R. Gordon KB, et al. Among authors: leonardi cl. J Dermatolog Treat. 2006;17(1):9-17. doi: 10.1080/09546630500472838. J Dermatolog Treat. 2006. PMID: 16467018 Clinical Trial.

8

Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database.

Gottlieb AB, Leonardi CL, Goffe BS, Ortonne JP, van der Kerkhof PC, Zitnik R, Nakanishi A, Jahreis A. Gottlieb AB, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S92-100. doi: 10.1016/j.jaad.2005.10.053. J Am Acad Dermatol. 2006. PMID: 16488335

9

Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.

Gottlieb AB, Hamilton T, Caro I, Kwon P, Compton PG, Leonardi CL; Efalizumab Study Group. Gottlieb AB, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S154-63. doi: 10.1016/j.jaad.2005.12.018. J Am Acad Dermatol. 2006. PMID: 16488337 Clinical Trial.

10

Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.

Papp KA, Miller B, Gordon KB, Caro I, Kwon P, Compton PG, Leonardi CL; Efalizumab Study Group. Papp KA, et al. Among authors: leonardi cl. J Am Acad Dermatol. 2006 Apr;54(4 Suppl 1):S164-70. doi: 10.1016/j.jaad.2005.10.032. J Am Acad Dermatol. 2006. PMID: 16488338 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters